You are viewing the site in preview mode

Skip to main content

Table 2 Peri- and post-transplantation data

From: Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome—a single-center study

Variable Total N = 119 Alive N  = 96 Dead N  = 23 p
Age at transplantation (years) 53.1 (±10.5) 52.7 (±10.0) 55.0 (±12.2) 0.33
Assessment to transplant (years) 2.6 (1.1, 4.3) 1.3 (0.8, 3.5) 2.6 (1.2, 4.3) 0.09
Waiting list time (years) 2.4 (1.1, 4.2) 1.8 (0.7, 3.5) 2.5 (1.1, 4.3) 0.02*
Mycophenolic acid 62 (52.1) 53 (55.2) 9 (39.1) 0.14
Azathioprine 45 (37.9) 31 (32.2) 14 (60.8) 0.07
Prednisolone 119 96 (100) 23 (100)  
Tacrolimus 57 (47.9) 46 (47.9) 11 (47.8) 0.92
Cyclosporin 45 (37.9) 34 (35.4) 11 (47.8) 0.64
Sirolimus 3 (2.5) 3 (3.1) 0 (0)  
ACEI/ARB therapy post-transplant 22 (17.6) 20 (20.8) 2 (8.7) 0.18
Mean creatinine at censor (μmol/l) 188 (±38.2) 173 (±116) 253 (±151) 0.02
Biopsy-proven acute rejection 16 (13.4) 15 (15.6) 1 (4.3) 0.15
Delayed graft function 42 (35.3) 29 (30.2) 13 (56.5) 0.02*
  1. Data are numbers with percentage in parentheses, mean ± standard deviation or median (interquartile range). Tests of significance are t-test (parametric), Mann-Whitney (non-parametric) and Chi-square. ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker. *p < 0.05.